Brokerages Set Cerus Corporation (CERS) PT at $7.25

When looking at the past five sessions, the stock returned -7.81% losses and is down by -28.68% compared with its 200-day moving average of $3.04. The firm earned "Positive" rating on Friday, February 10 by Susquehanna. Citigroup has "Buy" rating and $160 target. As per Friday, March 24, the company rating was maintained by Jefferies. Provident Trust Co owns 1.77 million shares or 7.44% of their USA portfolio. The stock has "Overweight" rating by Barclays Capital on Thursday, October 6. Moreover, Proshare Advisors Ltd has 0% invested in Cerus Corporation (NASDAQ:CERS). CERS's total short interest was 10.79 million shares in September as published by FINRA.

Among 3 analysts covering Cerus (NASDAQ:CERS), 2 have Buy rating, 0 Sell and 1 Hold. Cerus Corporation has a one year low of $1.93 and a one year high of $6.59. Cerus Corporation (NASDAQ:CERS) has declined 40.83% since September 19, 2016 and is downtrending. The stock rose 1.21% or $0.23 reaching $18.83. It has underperformed by 57.53% the S&P500.

The market capitalization of Cerus Corporation is at $273.74 Million. The stock's market cap is $270.66 million. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. Equities analysts forecast that Cerus Corporation will post ($0.68) earnings per share for the current fiscal year. The Company operates through blood safety segment. The institutional investor bought 500,000 shares of the biotechnology company's stock, valued at approximately $1,255,000. Its up 0.30, from 1.46 in 2016Q3. It improved, as 16 investors sold Cerus Corporation shares while 30 reduced holdings. Stevens Mngmt Ltd Partnership invested in 0% or 14,858 shares. Amalgamated National Bank owns 12,462 shares for 0% of their portfolio. The biotechnology company reported ($0.16) earnings per share for the quarter, meeting the consensus estimate of ($0.16).

Shares of Cerus Corporation (NASDAQ:CERS) have been assigned an average rating of "Hold" from the seven brokerages that are now covering the firm, reports. Sg Americas Securities Lc owns 41,260 shares for 0% of their portfolio. Weiss Multi invested in 20,000 shares. Accern also gave news stories about the biotechnology company an impact score of 44.6014765814862 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. 820 were reported by Bessemer Gp. (NASDAQ:KFRC). Wells Fargo Company Mn stated it has 50,048 shares or 0% of all its holdings. Manufacturers Life Insurance Communication The reported 0% of its portfolio in Cerus Corporation (NASDAQ:CERS). BidaskClub raised shares of Cerus Corporation from a "sell" rating to a "hold" rating in a report on Tuesday, August 8th. Blackrock reported 10,260 shares stake. Broadview Advisors Llc sold 139,000 shares as Kforce Inc (KFRC)'s stock declined 26.19%. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. Therefore 67% are positive. Finally, BTIG Research reissued a "buy" rating and issued a $5.00 price target on shares of Cerus Corporation in a report on Sunday, May 28th. The firm has "Neutral" rating given on Thursday, December 17 by Wedbush. The firm earned "Buy" rating on Tuesday, August 11 by Zacks. On Wednesday, August 19 the stock rating was maintained by BTIG Research with "Buy".

The Boeing Company is an aerospace company. The company has market cap of $149.22 billion. It has a 20.63 P/E ratio. T.J.

Investors sentiment decreased to 0.86 in Q4 2016. Its up 0.60, from 0.7 in 2016Q3. 17 funds opened positions while 39 raised stakes. Pier Limited Liability Corporation has 808,200 shares for 0.64% of their portfolio. Blair William & Il has 144,778 shares. Wells Fargo & Mn owns 3.16M shares. Thompson Davis owns 226 shares for 0.06% of their portfolio. East Coast Asset Mgmt Limited Com accumulated 3,393 shares. "Similarly, the company's CFO Green Kevin Dennis on 2017-03-15 Sell 2343 shares of the company at a price of $4.21". Utd Capital Financial Advisers Limited Liability Company stated it has 151,046 shares. At one point in the past year, the shares traded as low as $38.58 but has recovered 53.29% since then. Moreover, Bankshares Of Ny Mellon Corp has 0.3% invested in Boeing Co (NYSE:BA). New York-based Cannell Peter B & Incorporated has invested 0.17% in Boeing Co (NYSE:BA). Investors measure stock performance on the basis of a company's earnings power.

Since May 5, 2017, it had 0 insider purchases, and 3 insider sales for $371,286 activity. We have $2.31 PT which if reached, will make NASDAQ:CERS worth $16.11M less.

Analysts await Kforce Inc. After $-0.16 actual EPS reported by Cerus Corporation for the previous quarter, Wall Street now forecasts 0.00% EPS growth. TJX's profit will be $636.30 million for 18.22 P/E if the $1.00 EPS becomes a reality.

Receive Cerus Corporation News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus Corporation with's FREE daily email newsletter.

Like this


21 September 2017
Enjoy the benefits of hunting, fishing
Collectively, the nation's unique "user pays-public benefits" system brought in $64 million to fund conservation efforts in IL .

21 September 2017
Pentagon Confirms South Korea Actually Considering Nuclear Rearmament
Treasury Secretary Steven Mnuchin had said he would plan to impose financial sanctions against Chinese institutions if Beijing violates global embargo agreements.

21 September 2017
Stock is up at $33.83 (STLD) Steel Dynamics Provides Third Quarter…
A few investment analysts have issued ratings on the stock. (NDAQ: STLD ) from Neutral to Buy in a report released on 6/19/2017. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock.

21 September 2017
Celldex Therapeutics, Inc. (CLDX) Receives $8.08 Consensus Target Price from Analysts
Raymond James Financial Services Advisors boosted its stake in stocks of Celldex Therapeutics by 26.2% through out the 1st period. Zacks Investment Research lowered Celldex Therapeutics from a "buy" rating to a "sell" rating in a report on Monday, July 17th.

21 September 2017
18-Year-Old Arrested For Murder of Another Teen
Police previously said Williams was meeting another teen at the park when he was shot three times in the stomach Sunday night. Sunday evening when someone approached the auto and shot Williams multiple times in the chest.

21 September 2017
Ric Flair talks his recent health scare, battle with alcoholism
His fiancee, Wendy Barlow , said the 68-year-old wrestling legend was dealing with multiple organ problems. He was placed into a medically induced coma shortly after that and was rushed into surgery.

21 September 2017
Rosh Hashanah 2017 - 2018 Dates & Times
Yaakov Finkelstein, Consul General of Israel in Mumbai, said, "The Rosh Hashanah symbolises a new beginning". It is traditionally marked by the blowing of a ceremonial ram's horn known as a shofar.

21 September 2017
Jordy Nelson (quad) returned to practice for Packers on Wednesday
Those guys will all work in either the rehab group and hopefully move to limited or start in limited and hopefully move to full. Favre, who threw five interceptions in that game, was sacked on the next play after order was restored, ending the game.

21 September 2017
Wings sell melted ice vials from The Joe for $85
For $85, fans can purchase a vial of melted ice the Red Wings skated on during the Farewell Season at The Joe. Proceeds will benefit the foundation's efforts to continue supporting the sport of hockey.

21 September 2017
FedEx's first quarter earnings disappoint, impacted by TNT Express cyberattack, Hurricane Harvey
In other FedEx Corporation news, Director Kim Jabal sold 5,918 shares of the stock in a transaction dated Friday, June 23rd. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.